Literature DB >> 12602924

Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.

Hidefumi Sasaki1, Chih-Yi Yu, Meiru Dai, Carmen Tam, Massimo Loda, Daniel Auclair, Lan Bo Chen, Anthony Elias.   

Abstract

Periostin is a recently identified gene that is preferentially expressed in periosteum, indicating a potential role in bone formation and maintenance of structure. We independently identified and isolated periostin from cancer tissue, using the palindromic PCR-driven cDNA Differential Display technique. For the present work, we developed a novel sandwich chemiluminescence assay to detect serum periostin level using newly developed monoclonal and polyclonal antibodies. We investigated serum periostin levels in breast cancer and small cell lung cancer patients, especially in patients with bone metastasis. The study included 58 breast cancer and 44 small cell lung cancer patients. Serum periostin levels were elevated in breast cancer patients presenting with bone metastases (92.0 +/- 28.6 ng/ml) compared to similar breast cancer patients without evidence of bone metastasis (55.0 +/- 16.6 ng/ml, p = 0.04). No correlation was found between the serum periostin level and any other prognostic factors, such as clinical stage and lymph node metastasis in breast cancer. Serum periostin levels thus appear to serve as a marker of bone metastasis from breast cancer. In contrast, serum periostin levels were similar in samples from patients with small cell lung cancer who did or did not have bone metastasis. However, increasing T-stage and N-stage of patients with small cell lung cancer were correlated with higher periostin levels (T4, 126.5 +/- 29.7 ng/ml v.s. T2, 64.9 +/- 16.1 ng/ml, p = 0.03; and T4 v.s. T1, 36.3+/- 7.5 ng/ml, p = 0.01; N3, 108.7 +/- 17.3 ng/ml v.s. N2, 49.7+/- 10.9 ng/ml, p = 0.01). Periostin has a substantial homology with the insect cell adhesion molecule, fasciclin I. Thus, expression of periostin may facilitate tumor cell adhesion to the bone surface. In fact, we found by in situ RNA hybridization, that the periostin gene was highly expressed in the stromal cells immediately surrounding the tumor, but not within the breast cancer cells themselves.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602924     DOI: 10.1023/a:1021899904332

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  57 in total

1.  Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litivn
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 2.  Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.

Authors:  Jieqing Zhu; Gaofeng Xiong; Christine Trinkle; Ren Xu
Journal:  Histol Histopathol       Date:  2014-03-28       Impact factor: 2.303

Review 3.  The multiple facets of periostin in bone metabolism.

Authors:  B Merle; P Garnero
Journal:  Osteoporos Int       Date:  2012-02-07       Impact factor: 4.507

Review 4.  Bone markers in osteoporosis.

Authors:  Patrick Garnero
Journal:  Curr Osteoporos Rep       Date:  2009-09       Impact factor: 5.096

5.  Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.

Authors:  Pedram Heidari; Shadi A Esfahani; Nazife S Turker; Gabrielle Wong; Timothy C Wang; Anil K Rustgi; Umar Mahmood
Journal:  J Nucl Med       Date:  2015-06-11       Impact factor: 10.057

6.  Prognostic value of periostin in early-stage breast cancer treated with conserving surgery and radiotherapy.

Authors:  Changyou Li; Jing Xu; Qi Wang; Shaoqing Geng; Zheng Yan; Jin You; Zhenfeng Li; Xiao Zou
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

7.  Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression.

Authors:  Rong Shao; Shideng Bao; Xuefang Bai; Carrie Blanchette; Ryan M Anderson; Tongyun Dang; Mikhail L Gishizky; Jeffrey R Marks; Xiao-Fan Wang
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Expression of periostin and its clinicopathological relevance in gastric cancer.

Authors:  Jun-Sheng Li; Guang-Wen Sun; Xiao-Ying Wei; Wen-Hao Tang
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

9.  IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.

Authors:  Michal Rajski; Rosanna Zanetti-Dällenbach; Brigitte Vogel; Richard Herrmann; Christoph Rochlitz; Martin Buess
Journal:  BMC Med       Date:  2010-01-05       Impact factor: 8.775

10.  Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Authors:  Kusumawadee Utispan; Peti Thuwajit; Yoshimitsu Abiko; Komgrid Charngkaew; Anucha Paupairoj; Siri Chau-in; Chanitra Thuwajit
Journal:  Mol Cancer       Date:  2010-01-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.